Metabolic Reprogramming in Kidney Diseases: Evidence and Therapeutic Opportunities
Metabolic reprogramming originally referred to the ability of cancer cells to metabolically adapt to changes in environmental conditions to meet both energy consumption and proliferation requirements. According to recent studies, renal cells are also capable of reprogramming their metabolism after k...
Guardado en:
Autores principales: | Yin Li, Zixin Sha, Hui Peng |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hindawi Limited
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9a4959b5e70640e2a7ea1e095584eeac |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
[51] The horseshoe kidney: Pathological and therapeutic aspects
por: Megri Rochdi, et al.
Publicado: (2018) -
Possible Therapeutic Effect of Exercise for Incurable Diseases
por: Il-Gyu Ko
Publicado: (2021) -
Severe COVID-19 in a patient with chronic kidney disease: Is there a positive effect of continuous venovenous hemodiafiltration?
por: Xue Xing, et al.
Publicado: (2021) -
Psychosocial determinants of cardiovascular events among black Americans with chronic kidney disease or associated risk factors in the Jackson heart study
por: Nrupen A. Bhavsar, et al.
Publicado: (2021) -
SARS-CoV-2 infection in patients with chronic kidney disease on haemodialysis. Evolution of SARS-CoV-2 CRP
por: José Zúñiga, et al.
Publicado: (2021)